CW Form 144 filing: sale of 5,047 shares valued at $2.92M

CW: A security holder filed a Form 144 notice to sell up to 5,047 shares of common stock, with an aggregate market value of $2,916,721.36.

Rhea-AI Filing Summary

CW: A security holder filed a Form 144 notice to sell up to 5,047 shares of common stock, with an aggregate market value of $2,916,721.36. The filing lists UBS Financial Services Inc. as broker and identifies the NYSE as the exchange, with an approximate sale date of 11/12/2025.

The shares to be sold were acquired through restricted stock units (RSUs) and performance share vesting across multiple dates from 2019 to 2023. Shares outstanding were reported as 36,874,638; this is a baseline figure, not the amount being offered.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CW disclose in this Form 144 filing?

A holder filed to sell up to 5,047 shares of common stock under Rule 144.

What is the aggregate market value of the planned sale for CW?

The filing lists an aggregate market value of $2,916,721.36 for the shares.

When is the approximate sale date in the CW Form 144?

The approximate sale date stated is 11/12/2025.

Which broker and exchange are listed for the CW shares?

The broker is UBS Financial Services Inc., and the exchange is the NYSE.

How were the CW shares to be sold acquired?

They were acquired via RSUs and performance share vesting on several dates from 2019–2023.

How many CW shares were outstanding?

The filing reports 36,874,638 shares outstanding.

Does the CW Form 144 involve the company issuing new shares?

No. It is a planned sale by a security holder under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 09:48 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001621241
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CURTISS WRIGHT CORP
SEC File Number	001-00134
Address of Issuer	130 HARBOUR PLACE DRIVE SUITE 300 DAVIDSON NORTH CAROLINA 28036
Phone	7048694600
Name of Person for Whose Account the Securities are To Be Sold	Farkas K Christopher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	5047	2916721.36	36874638	11/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2022	Performance share vesting	Issuer			507	01/01/2022	NA
Common	03/19/2023	RSU	Issuer			1143	03/19/2023	NA
Common	03/15/2021	RSU	Issuer			384	03/15/2021	NA
Common	02/04/2020	Performance share vesting	Issuer			474	02/04/2020	NA
Common	11/17/2019	RSU	Issuer			267	11/17/2019	NA
Common	02/14/2023	Performance share vesting	Issuer			1755	02/14/2023	NA
Common	03/14/2022	RSU	Issuer			517	03/14/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This filing is for shares executed on 11/11/2025 and filed on 11/12/2025 due to the SEC closure for Veterans Day.
Date of Notice	11/12/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Christopher Farkas
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)